Study Evaluating PPM-204 In Subjects With Type 2 Diabetes

Stopped early · Phase 2

Conditions studied: Diabetes Mellitus

In brief

The purpose of this study is to learn whether PPM-204 has an effect on lowering blood glucose (blood sugar) levels and is safe in treating people with type 2 diabetes.

Key facts

Study ID

NCT00425919

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

500

Starts

2007-01-01

Expected to finish

2007-10-01

Last updated by the study team

2007-12-27

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Men and women of non-childbearing potential, 18 to 70 years old
• Subjects currently treated with diet and exercise alone and subjects receiving a single oral antidiabetic medication
• BMI > 23 and < 43
• For subjects currently treated with 1 antidiabetic medication: HbA1c is greater than or equal to 6.8% and less than or equal to 8.5%.
• For subjects not currently treated with antidiabetic medications: HbA1c is greater than or equal to 7.2% and less than or equal to 9.0%

You may not qualify if…

• Subjects requiring insulin therapy
• Subjects currently receiving 2 or more oral antidiabetic medications
• Subjects requiring systemic corticosteroids, unless treatment was discontinued at least 4 weeks before the screening visit
• Subjects receiving warfarin
• Subjects currently receiving thiazolidinediones, unless treatment was discontinued 8 weeks before the screening visit
• Significant diabetic complications (retinopathy, nephropathy, symptomatic neuropathy)

Where it is running

• Study site — Los Angeles, California, United States
• Study site — Chipley, Florida, United States
• Study site — Destin, Florida, United States
• Study site — Marianna, Florida, United States
• Study site — West Palm Beach, Florida, United States
• Study site — Omaha, Nebraska, United States
• Study site — New York, New York, United States
• Study site — Austin, Texas, United States
• Study site — Richmond, Virginia, United States
• Study site — Tacoma, Washington, United States
• Study site — Buenos Aires, Argentina
• Study site — Corrientes, Argentina
• Study site — La Plata, Argentina
• Study site — Mar Del Plata Pcia de Bs. As, Argentina
• Study site — Ramos Mejia, Pcia de Bs., Argentina
• Study site — Daws Park, South Australia, Australia
• Study site — Keswick, South Australia, Australia
• Study site — Box Hill, Victoria, Australia
• Study site — Vila Clementino - Sao Paulo, Brazil
• Study site — Edmonton, Alberta, Canada
• Study site — Toronto, Ontario, Canada
• Study site — Charlottetown, Prince Edward Island, Canada
• Study site — Laval, Quebec, Canada
• Study site — Saint-Janvier, Quebec, Canada
• Study site — Artesia, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.